SCHEMBL21532476

SCHEMBL21532476

c1ccc(-c2nnn(-c3cccc4c3c3ccccc3n4-c3cccc(-n4c5ccccc5c5c4ccc4c6ccccc6n(-c6ccccc6)c45)c3)c2-c2ccccc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
IL1R1 P14778 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532772 0.96 L3MBTL1 (0.35) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532409 0.94 SMN1; SMN2 (0.36) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL17636687 0.92 L3MBTL1 (0.39) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532768 0.90 L3MBTL1 (0.35) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532764 0.90 L3MBTL1 (0.35) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532147 0.90 NPC1 (0.36) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532509 0.89 L3MBTL1 (0.36) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532510 0.89 L3MBTL1 (0.36) L3MBTL1KDM4EATMSMN1; SMN2NPC1
SCHEMBL21532229 0.89 NPC1 (0.32) SMN1; SMN2NPC1RAB9A
SCHEMBL15762174 0.89 KDM4E (0.41) L3MBTL1KDM4EATMSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 L3MBTL1 370/4885KDM4E 4144/4885ATM 622/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 L3MBTL1 242/4885KDM4E 3893/4885ATM 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.